Inventor · Palo Alto, CA, US

Jian Luo

38Patents
15h-index
64Co-inventors
84Inventor score

Filing activity: Jun 6, 1995 → Sep 5, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US6613802B1 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Human Necessities 70 Expired
US5827898A Use of bisphenolic compounds to treat type II diabetes Human Necessities 51 Expired
US9273107B2 Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases Physics 36 Active
US9889178B2 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having nonalcoholic steatohepatitis Physics 25 Active
US9925242B2 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of nonalcoholic steatohepatitis Physics 25 Active
US9889177B2 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having primary sclerosing cholangitis Physics 25 Active
US9895416B2 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having cholestasis Physics 25 Active
US9878009B2 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having error of bile acid synthesis Physics 25 Active
US9878008B2 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having bile acid diarrhea or bile acid malabsorption Physics 25 Active
US5674900A Terpenoid-type quinones for treatment of diabetes Chemistry; Metallurgy 23 Expired
US6624194B1 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Chemistry; Metallurgy 20 Expired
US9974833B2 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having pregnancy intrahepatic cholestasis Physics 19 Active
US6262118A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia Human Necessities 19 Expired
US6646004B1 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia Human Necessities 15 Expired
US7816367B2 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Chemistry; Metallurgy 15 Active
US5629319A Hypoglycemic agent from cryptolepis Chemistry; Metallurgy 12 Expired
US9161968B2 Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists Human Necessities 11 Active
US9770486B2 Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists Human Necessities 9 Active
US10434144B2 Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders Physics 9 Active
US7576131B2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Chemistry; Metallurgy 8 Expired
US8030354B2 Substituted biphenyl GPR40 modulators Chemistry; Metallurgy 7 Active
US10744185B2 Methods of using variants of FGF19 polypeptides for the treatment of pruritus Human Necessities 7 Active
US7649110B2 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Chemistry; Metallurgy 6 Active
US10688130B2 Methods and compositions for treating aging-associated conditions Human Necessities 5 Active
US5628999A Hypoglycemic agent from cryptolepis Chemistry; Metallurgy 4 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.